Key facts
- xCures’s last known valuation is $34.8M (Dec 2022).
- It has raised $34.7M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($12.7M) in Jun 2021.
- Notable investors include Metaplanet Holdings, JHH vc, Lauder Partners, Boehringer Ingelheim Venture Fund, HealthTech Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for xCures
Funding rounds
1 roundsAbout xCures
Developer of an AI-assisted clinical data platform designed to replace manual processes for acquiring, reading, and re-entering medical records. The company offers direct integration with Health Information Networks, a proprietary Record Locator, and an AI-powered data pipeline for normalization and extraction, enabling telehealth platforms, diagnostics firms, payers, and provider systems to access verifiable medical data, reduce workflow friction, and make better evidence-driven decisions.
- Industry
- Medical Records Systems
- Sector
- Healthcare
- HQ
- Oakland, CA, United States
- Founded
- 2018
- Employees
- 45
- Website
- xcures.com/
- Ownership
- Privately Held (backing)
xCures doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in xCures shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on xCures in its N-PORT filings yet. We sweep new filings monthly.